|

Tumor-Derived FGF19

RECRUITINGSponsored by University of Central Florida
Actively Recruiting
SponsorUniversity of Central Florida
Started2023-06-06
Est. completion2025-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06068257

Summary

Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* The study will enroll adult persons with breast cancer or colorectal cancer or no cancer (healthy controls) who are able to do a fasting blood draw.

(Pregnant women may choose to be in the study. The study procedures do not pose a risk to the safety of the unborn child or the woman.)

Exclusion Criteria:

* The study will not enroll persons who are unable or unwilling to provide informed consent.
* Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.

Conditions4

Breast CancerCancerColorectal CancerHealthy

Locations1 site

Burnett School Biomedical Sciences
Orlando, Florida, 32816
Amoy Fraser, PhD, CCRP, PMP407-266-8742amoy.fraser@ucf.edu

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.